Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders
返回论文页
Short communication|更新时间:2023-08-29
|
Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders
Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders
Genes & Diseases2023年10卷第5期
作者机构:
1. Department of Nephrology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center,Zhejiang,Hangzhou,China,310052
2. The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health,Zhejiang,Hangzhou,China,310052
3. Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University,Beijing,China,100084
Yunfan Pan, Li Lin, Fan Yu, 等. Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders[J]. Genes & Diseases, 2023,10(5).
Yunfan Pan, Li Lin, Fan Yu, et al. Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders[J]. Genes & Diseases, 2023,10(5).
Yunfan Pan, Li Lin, Fan Yu, 等. Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.10.002.
Yunfan Pan, Li Lin, Fan Yu, et al. Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders[J]. Genes & Diseases, 2023,10(5). DOI: 10.1016/j.gendis.2022.10.002.
Cysteine mutations impair the structural stability of phosphomannomutase 2 (PMM2) in glycosylation-associated metabolic disorders